Innovative methods to understand cancer risk and outcomes
Methodologic Innovations in Cancer Epidemiology
This study is looking at how different factors can affect the development and progression of colorectal cancer, with the goal of helping patients by creating better ways to predict outcomes and improve prevention and treatment strategies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11031990 on NIH RePORTER |
What this research studies
This research investigates how different risk factors contribute to the development and progression of cancers, particularly colorectal cancer. It aims to create advanced models that analyze exposure data before and after cancer diagnosis to better predict outcomes. By examining various stages of cancer development, including the formation of polyps and subsequent cancer incidence, the study seeks to improve understanding of how these factors influence survival rates. Patients may benefit from insights that could lead to more personalized prevention and treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for colorectal cancer, particularly those with a history of advanced polyps or other related risk factors.
Not a fit: Patients with cancers unrelated to colorectal cancer or those who are not at risk for developing colorectal cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer risk assessment and tailored prevention strategies for patients.
How similar studies have performed: Previous research has shown promise in using innovative modeling approaches to understand cancer risk factors, suggesting that this methodology could yield valuable insights.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Rosner, Bernard a — Brigham and Women's Hospital
- Study coordinator: Rosner, Bernard a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.